B0F Stock Overview
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Paxman AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.97 |
| 52 Week High | kr3.45 |
| 52 Week Low | kr2.10 |
| Beta | 0.71 |
| 1 Month Change | -3.88% |
| 3 Month Change | -7.48% |
| 1 Year Change | 9.19% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -40.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| B0F | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.0% | 2.6% | 1.2% |
| 1Y | 9.2% | -8.3% | 2.0% |
Return vs Industry: B0F exceeded the German Medical Equipment industry which returned -8.3% over the past year.
Return vs Market: B0F exceeded the German Market which returned 2% over the past year.
Price Volatility
| B0F volatility | |
|---|---|
| B0F Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: B0F has not had significant price volatility in the past 3 months.
Volatility Over Time: B0F's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 91 | Richard Paxman | paxmanscalpcooling.com |
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various clinics and treatment centers, and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device.
Paxman AB (publ) Fundamentals Summary
| B0F fundamental statistics | |
|---|---|
| Market cap | €61.43m |
| Earnings (TTM) | €704.21k |
| Revenue (TTM) | €18.86m |
87.2x
P/E Ratio3.3x
P/S RatioIs B0F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B0F income statement (TTM) | |
|---|---|
| Revenue | kr220.61m |
| Cost of Revenue | kr74.19m |
| Gross Profit | kr146.42m |
| Other Expenses | kr138.18m |
| Earnings | kr8.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 23, 2024
| Earnings per share (EPS) | 0.43 |
| Gross Margin | 66.37% |
| Net Profit Margin | 3.73% |
| Debt/Equity Ratio | 11.1% |
How did B0F perform over the long term?
See historical performance and comparison